Dialogue Health Technologies
Dialogue is a Canadian virtual healthcare provider for organizations, offering an Integrated Health Platform with EAP, mental health, and primary care.
Secondary Market Price
How Dialogue Health Technologies Measures Up
To help you manage your Dialogue Health Technologies equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series B
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Dialogue Health Technologies's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Dialogue Health Technologies Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Dialogue Health Technologies's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Dialogue Health Technologies is a Canadian company that provides virtual care and well-being programs to organizations. Its primary offering is an Integrated Health Platform™ that gives employees access to an Employee Assistance Program (EAP), Mental Health+, Primary Care, and Wellness services through a single application. The company's services are utilized by over 50,000 organizations. Specific details about the company's history, such as its founding date or key milestones, are not publicly detailed.
Looking ahead, Dialogue has announced plans to expand its platform with a new care offering for Women's and Family Health, slated for a 2026 launch. The company also produces resources for organizational leaders, including its recently published '2025 State of workplace well-being' report, which offers data on employee wellness and EAP decision-making. Another recent initiative includes a virtual event focused on the financial costs associated with neglecting women's health in the workplace.
- Sun Life Financial
- Caisse de dépôt et placement du Québec
- Portag3 Ventures
- White Star Capital
- HV Holtzbrinck Ventures
- First Ascent Ventures
- Walter Ventures
- Co-Founder, Cherif Habib
- Co-Founder, Alexis Smirnov
- Co-Founder, Anna Chif
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Dialogue Health Technologies worth joining?
Deciding to join a company depends on many personal and financial factors that are unique to your situation. Prospect can help you analyze the potential value of an equity offer by comparing it to other opportunities, giving you a clearer financial picture before you make a decision.
What should I do with my Dialogue Health Technologies stock?
Managing private company stock involves complex decisions around taxes, timing, and potential value that can significantly impact your financial outcome. Prospect provides personalized, multi-year strategies for exercising options and selling shares to help you maximize your post-tax returns.
Can you sell Dialogue Health Technologies stock?
Selling stock in a private company is typically possible during specific events like tender offers or on secondary markets, but it is not as straightforward as selling public stock. Prospect offers tender offer tools and access to secondary market data to help you navigate these liquidity opportunities effectively.
How can I find the value of my Dialogue Health Technologies stock?
Valuing stock in a private company is difficult due to the lack of public market data and the illiquid nature of the shares. You can use Prospect to get a data-driven valuation, as its platform analyzes factors like funding rounds and secondary market prices to project your equity's future worth.
What is Dialogue Health Technologies's equity worth?
The exact worth of private equity fluctuates and is hard to determine without sophisticated analysis of the company and market trends. Prospect's predictive models can provide a likely range for your equity's value by using data similar to what venture capitalists use for their own investment decisions.
What is Dialogue Health Technologies's stock ticker symbol?
As a private, pre-IPO company, Dialogue Health Technologies does not have a stock ticker symbol. Ticker symbols are only assigned to companies when they become publicly traded on a stock exchange.
Can I buy or sell Dialogue Health Technologies stock?
As an employee, you can typically "buy" stock by exercising your options, and you can sell shares during company-approved liquidity events like tender offers. Prospect helps you create tax-optimized strategies for both exercising options and selling shares to improve your financial outcome.
What is the criteria to buy or invest in Dialogue Health Technologies stock?
Investing in a private company like Dialogue Health Technologies is generally restricted to employees receiving equity compensation or accredited investors participating in private financing rounds. If you are an employee with stock options, Prospect can help you understand the financial implications and create a plan for exercising them.
